1-207124335-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000715.4(C4BPA):​c.675T>C​(p.Gly225Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.846 in 1,612,826 control chromosomes in the GnomAD database, including 578,171 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.86 ( 56324 hom., cov: 31)
Exomes 𝑓: 0.84 ( 521847 hom. )

Consequence

C4BPA
NM_000715.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.651
Variant links:
Genes affected
C4BPA (HGNC:1325): (complement component 4 binding protein alpha) This gene encodes a member of a superfamily of proteins composed predominantly of tandemly arrayed short consensus repeats of approximately 60 amino acids. Along with a single, unique beta-chain, seven identical alpha-chains encoded by this gene assemble into the predominant isoform of C4b-binding protein, a multimeric protein that controls activation of the complement cascade through the classical pathway. The genes encoding both alpha and beta chains are located adjacent to each other on human chromosome 1 in the regulator of complement activation gene cluster. Two pseudogenes of this gene are also found in the cluster. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 1-207124335-T-C is Benign according to our data. Variant chr1-207124335-T-C is described in ClinVar as [Benign]. Clinvar id is 402444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-207124335-T-C is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.651 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.897 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C4BPANM_000715.4 linkc.675T>C p.Gly225Gly synonymous_variant Exon 6 of 12 ENST00000367070.8 NP_000706.1 P04003
C4BPAXM_005273251.3 linkc.675T>C p.Gly225Gly synonymous_variant Exon 6 of 12 XP_005273308.1 P04003
C4BPAXM_005273252.5 linkc.675T>C p.Gly225Gly synonymous_variant Exon 6 of 12 XP_005273309.1 P04003

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C4BPAENST00000367070.8 linkc.675T>C p.Gly225Gly synonymous_variant Exon 6 of 12 1 NM_000715.4 ENSP00000356037.3 P04003

Frequencies

GnomAD3 genomes
AF:
0.859
AC:
130672
AN:
152038
Hom.:
56266
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.904
Gnomad AMI
AF:
0.807
Gnomad AMR
AF:
0.865
Gnomad ASJ
AF:
0.767
Gnomad EAS
AF:
0.796
Gnomad SAS
AF:
0.878
Gnomad FIN
AF:
0.880
Gnomad MID
AF:
0.772
Gnomad NFE
AF:
0.838
Gnomad OTH
AF:
0.839
GnomAD2 exomes
AF:
0.855
AC:
214046
AN:
250328
AF XY:
0.851
show subpopulations
Gnomad AFR exome
AF:
0.909
Gnomad AMR exome
AF:
0.905
Gnomad ASJ exome
AF:
0.771
Gnomad EAS exome
AF:
0.812
Gnomad FIN exome
AF:
0.882
Gnomad NFE exome
AF:
0.837
Gnomad OTH exome
AF:
0.835
GnomAD4 exome
AF:
0.845
AC:
1233705
AN:
1460670
Hom.:
521847
Cov.:
40
AF XY:
0.845
AC XY:
613903
AN XY:
726728
show subpopulations
African (AFR)
AF:
0.904
AC:
30214
AN:
33434
American (AMR)
AF:
0.902
AC:
40281
AN:
44674
Ashkenazi Jewish (ASJ)
AF:
0.775
AC:
20250
AN:
26120
East Asian (EAS)
AF:
0.788
AC:
31281
AN:
39672
South Asian (SAS)
AF:
0.876
AC:
75561
AN:
86232
European-Finnish (FIN)
AF:
0.884
AC:
47147
AN:
53340
Middle Eastern (MID)
AF:
0.817
AC:
4703
AN:
5758
European-Non Finnish (NFE)
AF:
0.841
AC:
934065
AN:
1111092
Other (OTH)
AF:
0.832
AC:
50203
AN:
60348
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
9480
18959
28439
37918
47398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
21124
42248
63372
84496
105620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.860
AC:
130791
AN:
152156
Hom.:
56324
Cov.:
31
AF XY:
0.862
AC XY:
64080
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.904
AC:
37560
AN:
41530
American (AMR)
AF:
0.865
AC:
13214
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.767
AC:
2662
AN:
3470
East Asian (EAS)
AF:
0.796
AC:
4131
AN:
5190
South Asian (SAS)
AF:
0.878
AC:
4230
AN:
4816
European-Finnish (FIN)
AF:
0.880
AC:
9301
AN:
10574
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.838
AC:
56965
AN:
67996
Other (OTH)
AF:
0.839
AC:
1767
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
939
1878
2816
3755
4694
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
896
1792
2688
3584
4480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.841
Hom.:
131086
Bravo
AF:
0.860
Asia WGS
AF:
0.812
AC:
2827
AN:
3478
EpiCase
AF:
0.826
EpiControl
AF:
0.826

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
1.6
DANN
Benign
0.41
PhyloP100
-0.65
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Loading publications...

Other links and lift over

dbSNP: rs1126618; hg19: chr1-207297680; COSMIC: COSV65536467; COSMIC: COSV65536467; API